JF
IMVT icon

Jump Financial’s Immunovant IMVT Stock Holding History

Jump Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.82M Buy
124,987
+80,785
+183% +$2.46M 0.04% 535
2026
Q1 		$1.1M Sell
44,202
-60,400
-58% -$1.56M 0.01% 886
2025
Q4 		$2.66M Sell
104,602
-191,658
-65% -$4.27M 0.03% 574
2025
Q3 		$4.78M Sell
296,260
-26,586
-8% -$430K 0.06% 424
2025
Q2 		$5.17M Buy
322,846
+122,011
+61% +$1.85M 0.06% 406
2025
Q1 		$3.43M Buy
200,835
+71,167
+55% +$1.49M 0.05% 427
2024
Q4 		$3.21M Buy
129,668
+68,312
+111% +$1.94M 0.07% 372
2024
Q3 		$1.75M Sell
61,356
-90,116
-59% -$2.66M 0.04% 576
2024
Q2 		$4M Buy
151,472
+56,472
+59% +$1.61M 0.08% 307
2024
Q1 		$3.07M Buy
95,000
+65,928
+227% +$2.41M 0.08% 280
2023
Q4 		$1.22M Buy
29,072
+17,046
+142% +$627K 0.04% 606
2023
Q3 		$462K Buy
+12,026
New +$272K 0.02% 1068
2023
Q2 		– Sell
-45,600
Closed -$707K – 1969
2023
Q1 		$707K Buy
+45,600
New +$791K 0.03% 747
2022
Q2 		– Sell
-18,700
Closed -$103K – 1805
2022
Q1 		$103K Sell
18,700
-54,200
-74% -$338K ﹤0.01% 1404
2021
Q4 		$621K Sell
72,900
-700
-1% -$5.78K 0.04% 561
2021
Q3 		$640K Sell
73,600
-65,435
-47% -$590K 0.05% 416
2021
Q2 		$1.47M Buy
139,035
+116,471
+516% +$1.63M 0.14% 182
2021
Q1 		$361K Buy
22,564
+14,264
+172% +$376K 0.03% 531
2020
Q4 		$383K Buy
+8,300
New +$384K 0.07% 484

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's IMVT Position: Q2 2026 in Review

Jump Financial increased its Immunovant (IMVT) stake by 183% in Q2 2026, buying an estimated $2.46M and bringing the position to 124,987 shares worth $4.82M. The position accounts for 0.04% of the portfolio, ranked #535.

Jump Financial first reported a position in IMVT in Q4 2020 and has held it in 19 quarters since. The position peaked at $5.17M in Q2 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jump Financial held 124,987 shares of Immunovant worth $4.82M as of Q2 2026.
  • Jump Financial bought 80,785 Immunovant shares in Q2 2026, an estimated $2.46M.
  • Immunovant made up 0.04% of Jump Financial's portfolio in Q2 2026, its #535 holding.
  • Jump Financial first reported a position in Immunovant in Q4 2020 and has held it in 19 quarters since.
  • Jump Financial's Immunovant position peaked at $5.17M in Q2 2025.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.